Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies
Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 86, pp. 340-352
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 744-757
Closed Access | Times Cited: 105
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 60
Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
Cheng‐Ta Li, Kai‐Chun Yang, Wei‐Chen Lin
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 141
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study
Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Biological Psychiatry (2018) Vol. 85, Iss. 7, pp. 596-605
Closed Access | Times Cited: 111
The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: A translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia
Elisa Guma, Eric Plitman, M. Mallar Chakravarty
Neuroscience & Biobehavioral Reviews (2019) Vol. 104, pp. 141-157
Open Access | Times Cited: 93
Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate
Kara Dempster, Peter Jeon, Michael Mackinley, et al.
Molecular Psychiatry (2020) Vol. 25, Iss. 8, pp. 1640-1650
Open Access | Times Cited: 81
Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies (N = 1501)
Yang Du, Lei Chen, Meichen Yan, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 3092-3103
Closed Access | Times Cited: 34
Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
Kirsten Borup Bojesen, Bjørn H. Ebdrup, Kasper Jessen, et al.
Psychological Medicine (2019) Vol. 50, Iss. 13, pp. 2182-2193
Open Access | Times Cited: 55
Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis
Kirsten Borup Bojesen, Brian V. Broberg, Birgitte Fagerlund, et al.
Biological Psychiatry (2020) Vol. 89, Iss. 3, pp. 278-287
Open Access | Times Cited: 51
A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia
Nina V. Kraguljac, Charity J. Morgan, Meredith A. Reid, et al.
Schizophrenia Research (2019) Vol. 210, pp. 239-244
Open Access | Times Cited: 44
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-Analysis
Thomas Whitehurst, Martin Osugo, Leigh Townsend, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 119, pp. 255-267
Closed Access | Times Cited: 38
Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Manabu Kubota, Sho Moriguchi, Keisuke Takahata, et al.
Schizophrenia Research (2020) Vol. 222, pp. 122-132
Closed Access | Times Cited: 35
Cannabidiol modulation of hippocampal glutamate in early psychosis
Aisling O’Neill, Luciano Annibale, Grace Blest‐Hopley, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 7, pp. 814-822
Open Access | Times Cited: 30
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Glutamate and Proton MR Spectroscopy in Schizophrenia
Teruki Koizumi, Ariel Graff‐Guerrero
Neuromethods (2025), pp. 159-173
Closed Access
Sleep quality is related to brain glutamate and symptom severity in schizophrenia
Stephanie A. Korenic, Elizabeth A. Klingaman, Emerson M. Wickwire, et al.
Journal of Psychiatric Research (2019) Vol. 120, pp. 14-20
Closed Access | Times Cited: 32
Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals
Pablo León-Ortíz, Luis F. Rivera-Chávez, Jiram Torres‐Ruiz, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 270-276
Closed Access | Times Cited: 8
Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status
Yvonne S. Yang, Jason Smucny, Huailin Zhang, et al.
NeuroImage Clinical (2023) Vol. 39, pp. 103461-103461
Open Access | Times Cited: 8
Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?
Ting Cao, Nana Li, Hualin Cai
Schizophrenia Research (2019) Vol. 226, pp. 95-110
Closed Access | Times Cited: 25
Resting-state functional connectivity in treatment response and resistance in schizophrenia: A systematic review
Nathan Chan, Julia Kim, Parita Shah, et al.
Schizophrenia Research (2019) Vol. 211, pp. 10-20
Closed Access | Times Cited: 23
Reduced in vivo visual cortex GABA in schizophrenia, a replication in a recent onset sample
Jong H. Yoon, Richard J. Maddock, Edward Cui, et al.
Schizophrenia Research (2019) Vol. 215, pp. 217-222
Open Access | Times Cited: 22
Disrupted GABAergic facilitation of working memory performance in people with schizophrenia
J. Daniel Ragland, Richard J. Maddock, Mitzi Hurtado, et al.
NeuroImage Clinical (2019) Vol. 25, pp. 102127-102127
Open Access | Times Cited: 22
Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders
Jamie J Lopes, Sean P. Carruthers, Denny Meyer, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 11, pp. 930-951
Open Access | Times Cited: 2
Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia
Juan Bustillo, Thomas R. Jones, Clifford Qualls, et al.
Journal of Affective Disorders (2018) Vol. 246, pp. 745-753
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top